Apollo Health Ventures
Investor profile
Venture capital
Apollo Health Ventures has backed 4 European tech companies across 4 funding rounds between 2022 and 2025, joining rounds totalling €80M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2022–2025
4 yrs
Total round €
€80M
sum of rounds joined
Deals by year
distinct rounds / yearApollo Health Ventures — deals by year — interactive chart.
Data table
| Apollo Health Ventures — deals by year | |
|---|---|
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Top sectors
by dealsApollo Health Ventures — top sectors — interactive chart.
Data table
| Apollo Health Ventures — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsApollo Health Ventures — stages — interactive chart.
Data table
| Apollo Health Ventures — stages | |
|---|---|
| Seed | 3 |
| Series A | 1 |
Countries
by dealsApollo Health Ventures — countries — interactive chart.
Data table
| Apollo Health Ventures — countries | |
|---|---|
| Germany | 1 |
| Netherlands | 1 |
| Switzerland | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- +ND Capital1
- 4see Ventures1
- AlbionVC1
- Alexandria Venture Investments1
- Athos Capital1
- Bernina BioInvest1
- Boehringer Ingelheim Venture Fund (BIVF)1
- Curie Capital B.V.1
- Earlybird Venture Capital1
- Eli lilly and company1
- High-Tech Gründerfonds (HTGF)1
- LifeLink Ventures1
- Longevitytech.fund1
- Longview Ventures1
- NRW.Venture1
- Oxford Science Enterprises (OSE)1
- Oxford University Innovation Fund1
- Parkwalk Advisors1
- ROM Utrecht Region1
- Schroders Capital1
- Sofinnova Partners1
- YZR Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| haya therapeutics | Switzerland | 1 | €58M |
| Scripta Therapeutics | UK | 1 | €10M |
| Refoxy Pharmaceuticals | Germany | 1 | €9.1M |
| Cleara Biotech B.V. | Netherlands | 1 | €2.6M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| haya therapeutics | Series A | €58M | 2025-05 |
| Scripta Therapeutics | Seed | €10M | 2025-11 |
| Refoxy Pharmaceuticals | Seed | €9.1M | 2024-12 |
| Cleara Biotech B.V. | Seed | €2.6M | 2022-09 |